Joshua Liang

Chief Strategy Officer & Board Director at Clover Biopharmaceuticals

Oversee company operations & strategy; since joining Clover in 2016, raised over RMB 750 million (~US$100 million) in total capital, grew FTE headcount 6x to nearly 200 by early 2020, initiated Clover's first clinical trials in Australia & China and led immuno-oncology R&D programs.

Former investment banker at Centerview Partners in the healthcare advisory practice, primarily focused in the life sciences sector

Links

Previous companies

UBS logo
Vertex Pharmaceuticals logo
Centerview Partners logo

Org chart

Teams

+10

Board of Directors

13 members

Timeline

  • Chief Strategy Officer & Board Director

    Current role

View in org chart